Samantha Semenkow
Stock Analyst at Citigroup
(0.84)
# 3,901
Out of 4,975 analysts
46
Total ratings
28.95%
Success rate
-20.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Initiates: Buy | $16 | $12.92 | +23.84% | 1 | Sep 2, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $13 → $10 | $1.70 | +488.24% | 4 | Aug 14, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $16 | $8.29 | +93.00% | 1 | Jul 16, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $3.72 | -59.68% | 3 | May 27, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.15 | +247.83% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $750.78 | +6.96% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $22.08 | +171.74% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $4.76 | +5.04% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $4.24 | +183.02% | 1 | Dec 2, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $27 → $31 | $20.29 | +52.78% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $2.96 | +406.76% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $8.32 | +861.54% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.94 | +255.33% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.76 | +443.48% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $59.44 | +21.13% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $17.14 | +191.72% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $20.88 | +168.20% | 3 | Aug 9, 2023 |
Roivant Sciences
Sep 2, 2025
Initiates: Buy
Price Target: $16
Current: $12.92
Upside: +23.84%
Cabaletta Bio
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $1.70
Upside: +488.24%
Wave Life Sciences
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $8.29
Upside: +93.00%
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $3.72
Upside: -59.68%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.15
Upside: +247.83%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $750.78
Upside: +6.96%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $22.08
Upside: +171.74%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.76
Upside: +5.04%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.24
Upside: +183.02%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $20.29
Upside: +52.78%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $2.96
Upside: +406.76%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $8.32
Upside: +861.54%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.94
Upside: +255.33%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.76
Upside: +443.48%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $59.44
Upside: +21.13%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $17.14
Upside: +191.72%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $20.88
Upside: +168.20%